The FDA has marked today’s international Rare Disease Day with a number of measures to promote research and patient participation in policy and research. Among the new measures ann
Grail, the US-based cancer detection startup backed by billionaires Jeff Bezos and Bill Gates is reportedly mulling a launch on the Hong Kong stock exchange.
Lantern Pharma, a pharma company which uses artificial intelligence to develop shelved oncology drugs has joined Genomics England’s groundbreaking industry partnership.
